The most overlooked organ in healthcare.

The asymmetry

If a patient walks into a GP's office with chest pain, they leave with an ECG, often a chest X-ray, frequently a referral for echocardiography or stress testing. The cardiovascular system is examined directly. Decisions are made on the basis of measurements, not on what the heart is presumed to be doing.

If a patient walks in with persistent breathlessness, the same logic applies. Spirometry. Imaging. Sometimes a sleep study. The respiratory system is interrogated.

If a patient walks in with cognitive symptoms — brain fog, persistent low mood, attention loss after a head knock, anxiety that won't shift — what tends to happen?

A history. A symptom questionnaire. A trial of medication. Sometimes a referral. Often a working diagnosis assembled from the patient's verbal report and the clinician's pattern-recognition.

The organ at the centre of all of those symptoms is rarely examined. Not because the technology doesn't exist — it does, and has for decades — but because the field hasn't yet built the workflow that puts brain imaging into routine cognitive-symptom care.

Why the gap exists

There are reasons. Some are reasonable. Some less so. The structural ones include cost, scarcity of trained operators, the fragmented way mental-health and neurological care are funded in most systems, and a longstanding clinical culture that treats the brain as the special province of psychiatry, neurology, or both — never both at once, rarely either when the symptoms are sub-syndromal.

The cultural ones are quieter and arguably more important. There is a residual sense, even now, that brain symptoms belong to the mind rather than the organ — and that asking to look at the organ is somehow indelicate, or reductive, or beside the point.

It isn't.

What the brain looks like, in working terms

The brain produces electrical activity continuously. It does so in characteristic patterns — slow rhythms when you're drifting off, faster ones when you're concentrating, particular signatures when you're scanning the environment for threat or settling into rest.

Those patterns can be measured. Quantitative electroencephalography (qEEG) records electrical activity from 19 sites on the scalp, processes the signal against an age-matched normative database, and produces a map of which frequencies are present where, and how those regions are communicating with each other. [1]

It is a functional measurement, not a structural one. It doesn't replace MRI. It doesn't diagnose neurological disease. What it does is give a picture of how the brain is working, second by second, while the patient is sitting there — at rest and during cognitive task.

That picture isn't always remarkable. Sometimes a qEEG looks unremarkable and the conversation moves to other contributors — sleep, autonomic regulation, gut-brain inputs, lifestyle. That, in itself, is useful: it changes the clinical question.

Other times the picture clarifies something the patient and the clinician have been circling for months. A pattern of slow-wave excess in the frontal regions, common in attention difficulties. [2] A pattern of beta over-activation in the right hemisphere, often seen alongside chronic anxiety. An asymmetry in alpha across the frontal poles, of the kind associated with persistent low mood. [3]

None of these patterns are the diagnosis. They are findings — measurements that, taken together with intake history and validated questionnaires, build a clinical picture that the patient and the clinician can both look at.

What changes when you look

Three things tend to shift when the brain becomes part of the examination instead of an assumption.

The conversation gets more specific. "I've got brain fog" becomes "the qEEG shows excess slow-wave in the frontal midline, our intake suggests fragmented sleep, and your last bloods showed low ferritin — these three things are likely related, and here's the order we think we should address them in."

The plan gets more honest. When you can measure something, you can also measure whether it's changing. Re-examination at the midpoint of a programme is the difference between "I think you might be feeling better" and "the cortical signature has moved toward your normative reference, and your sleep diary supports that."

The patient gets the picture. One of the consistent observations in clinic is that patients respond differently to a process that begins with looking. They ask better questions. They self-monitor more accurately. They take ownership of the next step in a way that's harder to reach when the entire formulation lives inside the clinician's head.

That last one matters more than it sounds. Most chronic brain-related complaints are not solved in a single visit. They are worked with, over time, through small adjustments to sleep, regulation, training, and lifestyle. A patient who has seen their own brain on a screen tends to be a more capable participant in that work than a patient who has been handed a prescription and a label.

What it isn't

To be clear about scope: qEEG is not magic, and it is not a substitute for the rest of medicine.

It does not diagnose epilepsy. It does not replace structural imaging when stroke or tumour is on the differential. It does not stand in for the work of psychiatrists, clinical psychologists, GPs, or sleep physicians. It is one input in a clinical workup — useful when the clinical question fits, less useful when it doesn't.

It also is not, in itself, a treatment. Looking at the brain doesn't change the brain. The change comes from what's done with the picture — sleep work, autonomic regulation, neurofeedback or biofeedback where indicated, functional neurological exercises, nutritional and lifestyle inputs, and, when appropriate, the ongoing care of the patient's primary medical and psychological practitioners.

The ask

The ask of the field, and of patients reading this, is small.

It is to treat the brain like the organ it is. To examine it directly when symptoms point that way, with the same plain-language intent that guides any other clinical examination. To stop relying entirely on a verbal account of symptoms when a measurement is available and would meaningfully inform the plan.

That doesn't require a revolution. It requires a workflow. The technology is available. The clinical reasoning is well-described in the published literature. The patients who would benefit from a more measurement-led approach to their brain-related symptoms are already in the system — they are simply not, yet, being looked at.

That is what we think is worth changing.

---

About the author. Dr Ash Connell is a chiropractor (AHPRA CHI0001772308), board-certified in quantitative EEG (QEEG-D), and the founding clinician of The Healthy Brain Clinic. He practises from Geelong and Camperdown, Victoria, and online Australia-wide. Read his bio →

References

1. Thatcher RW. (2010). Validity and reliability of quantitative electroencephalography (qEEG). Journal of Neurotherapy, 14(2), 122–152.
2. Arns M, Conners CK, Kraemer HC. (2013). A decade of EEG theta/beta ratio research in ADHD: a meta-analysis. Journal of Attention Disorders, 17(5), 374–383.
3. Coan JA, Allen JJB. (2004). Frontal EEG asymmetry as a moderator and mediator of emotion. Biological Psychology, 67(1–2), 7–49.

Editorial note. This article was drafted by Dr Ash Connell with structural support from a large language model, then reviewed for clinical accuracy and AHPRA compliance before publication. Citations are real, peer-reviewed sources. The clinical interpretations are Dr Ash's own.